TY - JOUR
T1 - Blastocyst development, MPF activity and ATP content of lamb oocytes supplemented with insulin-transferrin-selenium (ITS) and ascorbic acid at IVM
AU - María-Gracia, Catalá
AU - Montserrat, Roura
AU - Dolors, Izquierdo
AU - Roser, Morato
AU - Sondes, Hammami
AU - María-Teresa, Paramio
PY - 2013/5/1
Y1 - 2013/5/1
N2 - The aim of this study was to test the effect of insulin-transferrin-selenium (ITS), l-ascorbic acid (AA) and different hormone concentrations at IVM on blastocyst development, MPF activity and ATP content in lamb oocytes. In this study we used three maturation media: conventional IVM medium (CM), growth medium (GM: CM + ITS + AA and low level of hormones) and modified CM (MM: CM + ITS + AA and conventional hormone concentration). Cumulus-oocyte complexes (COCs) were classified into two categories according to results from BCB staining: fully grown oocytes or BCB+ and growing oocytes or BCB-A group of control oocytes (not BCB stained), BCB+ and BCB- were matured (IVM) for 24. h in CM (Treatments A, B and C, respectively). Also, BCB- oocytes were matured in four treatment groups: Treatment D: 12. h in GM plus 12. h in CM; Treatment E: 24. h in GM; Treatment F: 12. h in GM plus 12. h in MM; Treatment G: 24. h in MM. After IVM, oocytes were fertilized and cultured for 8 days and blastocyst development was assessed. Before and after IVM, a sample of each oocyte group was taken to evaluate MPF and ATP content. The BCB+ oocytes produced the highest blastocyst (13.3%) yield. BCB- oocytes did not show any statistically significant differences in blastocysts between treatments, D (5.9%), E (7.2%), F (2.9%) and G (3.9%) compared to Treatment C (4%). Results of MPF activity and ATP content assessed before and after IVM showed an increase in all oocytes (P<0.001) after 24. h of IVM compared to immature oocytes (0. h). No differences were observed among treatment groups. In conclusion, BCB- oocytes were unable to improve embryo development in any of the treatments tested in this study. Embryo development of BCB+ oocytes was significantly higher than BCB- oocytes. © 2012 Elsevier B.V.
AB - The aim of this study was to test the effect of insulin-transferrin-selenium (ITS), l-ascorbic acid (AA) and different hormone concentrations at IVM on blastocyst development, MPF activity and ATP content in lamb oocytes. In this study we used three maturation media: conventional IVM medium (CM), growth medium (GM: CM + ITS + AA and low level of hormones) and modified CM (MM: CM + ITS + AA and conventional hormone concentration). Cumulus-oocyte complexes (COCs) were classified into two categories according to results from BCB staining: fully grown oocytes or BCB+ and growing oocytes or BCB-A group of control oocytes (not BCB stained), BCB+ and BCB- were matured (IVM) for 24. h in CM (Treatments A, B and C, respectively). Also, BCB- oocytes were matured in four treatment groups: Treatment D: 12. h in GM plus 12. h in CM; Treatment E: 24. h in GM; Treatment F: 12. h in GM plus 12. h in MM; Treatment G: 24. h in MM. After IVM, oocytes were fertilized and cultured for 8 days and blastocyst development was assessed. Before and after IVM, a sample of each oocyte group was taken to evaluate MPF and ATP content. The BCB+ oocytes produced the highest blastocyst (13.3%) yield. BCB- oocytes did not show any statistically significant differences in blastocysts between treatments, D (5.9%), E (7.2%), F (2.9%) and G (3.9%) compared to Treatment C (4%). Results of MPF activity and ATP content assessed before and after IVM showed an increase in all oocytes (P<0.001) after 24. h of IVM compared to immature oocytes (0. h). No differences were observed among treatment groups. In conclusion, BCB- oocytes were unable to improve embryo development in any of the treatments tested in this study. Embryo development of BCB+ oocytes was significantly higher than BCB- oocytes. © 2012 Elsevier B.V.
KW - Blastocyst
KW - Growth medium
KW - IVF
KW - Lamb oocytes
U2 - https://doi.org/10.1016/j.smallrumres.2012.12.007
DO - https://doi.org/10.1016/j.smallrumres.2012.12.007
M3 - Article
VL - 112
SP - 103
EP - 107
JO - Small Ruminant Research
JF - Small Ruminant Research
SN - 0921-4488
ER -